[Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices].

Date publication

avril 2015

Journal

Bulletin du cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr RANGEARD Olivier

Tous les auteurs :
Marcy PY, Dahlet C, Brenet O, Yazbec G, Dubois PY, Salm B, Fouche Y, Mari V, Montastruc M, Lebrec N, Ancel B, Paillocher N, Dupoiron D, Rangeard O, Michel C, Chateau Y, Ettaiche M, Ferrero JM, Chamorey E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/25799876

Résumé

Most cancer patients require a totally-implanted central venous access device (TIVAD) for their treatment. This was a prospective, multicenter, open study to: (i) develop and validate a French-language questionnaire dubbed QASICC (Questionnaire for Acceptance of and Satisfaction with Implanted Central Venous Catheter) assessing patient's satisfaction with and acceptance of their TIVAD; (ii) develop a mean score of patient's acceptance and satisfaction; (iii) look for correlation between QASICC score and TIVAD patient/tumor pathology/device characteristics.

Mots clés

Cancer, Cathéter veineux central, Chambre à cathéter implantable, Dispositif veineux implantable, Neoplasms, Oncologie, Patient acceptance of health care, Patient's satisfaction, Qualité de vie, Questionnaire, Questionnaires, Satisfaction, Totally-implanted central venous access device, Validation studies, Vascular access devices, Venous catheter, Voie veineuse centrale, Étude de validation

Référence

Bull Cancer. 2015 04;102(4):301-15